Dr. Brian Johnson
Position title: Postdoctoral Researcher
PhD 2013, University of Wisconsin -Madison, Molecular and Environmental Toxicology
BS 2004, Michigan Technological University
- Johnson BP, Walisser JA, Liu Y, Shen AL, McDearmon EL, Moran SM, McIntosh BE, Vollrath AL, Schook AC, Takahashi JS, and Bradfield CA (2014) Hepatocyte circadian clock controls acetaminophen bioactivation through NADPH-cytochrome P450 oxidoreductase. Proc Natl Acad Sci U S A.
- Muganda-Rippchen D, Sheynkman G , Johnson BP , Smith LM , Bradfield CA, Craven M: Multi-View Clustering of Gene-Expression Time Series (In review)
- Sengupta S, Johnson BP, Swanson SA, Stewart R, Bradfield CA, and Thomson JA (2014) Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing. Toxicol Sci 140:236-245.
- Liu Y, Johnson BP, Shen AL, Wallisser JA, Krentz KJ, Moran SM, Sullivan R, Glover E, Parlow AF, Drinkwater NR, Schuler LA, and Bradfield CA (2014) Loss of BMAL1 in ovarian steroidogenic cells results in implantation failure in female mice. Proc Natl Acad Sci U S A.
- Mezrich J, Fechner J, Zhang X, Johnson B, Burlingham W, Bradfield C: An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells. Journal of Immunology 2010:3190-3198.
- Johnson BP, Moran S, Glover E, Mezrich J, Bradfield C: Activation of the Aryl Hydrocarbon Receptor in endothelia at birth is required for resolution of the ductus venosus. (In prep)
- Johnson BP, Liu Y, Stevens E, Moran S, Bradfield C: Aryl Hydrocarbon Receptor deficiency during late gestation results in endothelial mitochondrial dysfunction. (In prep)